WUXI BIOLOGICS
WuXi Biologics is a open-access technology platform company offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. Across the global biologics research and development community, we enable our partners to find innovative biological treatments for diseases worldwide.
WUXI BIOLOGICS
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2014-01-01
Status:
Active
Contact:
+86 (510)-8183-1205
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-17 | CMAB BioPharm | CMAB BioPharm acquired by WuXi Biologics | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-19 | Duality Biologics | WuXi Biologics investment in Series B - Duality Biologics | 90 M USD |
| 2020-09-30 | Invetx | WuXi Biologics investment in Series A - Invetx | 10.25 M USD |
| 2020-02-24 | Invetx | WuXi Biologics investment in Series A - Invetx | 15 M USD |
| 2019-05-21 | Inhibrx | WuXi Biologics investment in Convertible Note - Inhibrx | 40 M USD |
| 2019-04-23 | Duoning Biotech | WuXi Biologics investment in Series A - Duoning Biotech | 100 M CNY |
More informations about "WuXi Biologics"
WuXi Biologics withdraws from 2024 BIO convention …
May 1, 2024 Amid a U.S. biosecurity crackdown targeting certain Chinese manufacturers and contract research organizations, production specialist WuXi Biologics has quietly exited what is perhaps the biotech ...See details»
WuXi Biologics
A leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to …See details»
WuXi Biologics Achieves Major Milestones at Ireland Site with …
3 hours ago WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced major …See details»
WuXi Biologics Achieves Major Milestones at Ireland Site with …
4 hours ago Dundalk, Ireland, December 6, 2024 – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), …See details»
WuXi Biologics Achieves Major Milestones at Ireland Site with …
3 hours ago WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that …See details»
WuXi Biologics
A leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to …See details»
WuXi Biologics Recognized as Both Industry and Regional ESG …
Feb 21, 2024 WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that …See details»
Drugmakers race to find alternative suppliers as US …
Apr 11, 2024 WuXi Biologics, which focuses on medicines made from living cells known as biologics, generated 46 per cent of its revenue from the US. ... In March, the Biotechnology Innovation Organization (Bio ...See details»
WuXi out of biotech trade group, U.S. and China …
Mar 13, 2024 W ASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other ...See details»
WuXi Biologics Is a Global Contract Development, Manufacturing ...
Mar 27, 2024 WuXi Biologics differentiates itself from other well-established global contract development and manufacturing organizations, with its "follow-and-win the molecule" and …See details»
WuXi Biologics Achieves Major Milestones at Ireland Site with …
3 hours ago About WuXi Biologics. WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to …See details»
WuXi Biologics ESG
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to …See details»
WuXi Biologics Reports Solid 2024 Interim Results - Yahoo Finance
Aug 21, 2024 WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization …See details»
Biotech trade group pledges support to BIOSECURE Act - Fierce …
Mar 13, 2024 As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Washington, …See details»
WuXi Biologics beefs up its lobbying operation - STAT
May 16, 2024 WuXi Biologics has registered its own executives to lobby Congress for the first time as lawmakers look to crack down. ... following her abrupt exit from the organization. …See details»
Capabilities - WuXi Biologics
Quality. Expertise. Capacity. Speed. These are cornerstones of every service WuXi Biologics provides across the discovery to commercialization spectrum. Our CRDMO service offering …See details»
Wuxi Biologics Achieves Major Milestones At Ireland Site With …
22 hours ago Wuxi Biologics Achieves Major Milestones At Ireland Site With Multiple 16,000L PPQ Success And HPRA GMP Authorizations. 160.153.178.52. Tuesday, 02 January 2024 …See details»
WuXi Biologics Achieves Major Milestones at Ireland Site with …
3 hours ago WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that …See details»
WuXi Biologics withdraws from 2024 BIO convention amid …
WuXi Bio “will not have a presence” at the 2024 BIO International Convention in June, a spokesperson at the Biotechnology Innovation Organization has confirmed. A previous Fierce …See details»
Monoclonal Antibody Production - WuXi Biologics
This team embeds quality and compliance across the entire organization to ensure the products we manufacture are of the highest efficacy and safety standards and in line with your …See details»